Ayman J, Buzas A, Dochnal R, Palotai M, Jaszberenyi M, Bagosi Z
Biomedicines. 2025; 13(1).
PMID: 39857727
PMC: 11761252.
DOI: 10.3390/biomedicines13010143.
Ayman J, Palotai M, Dochnal R, Bagosi Z
Biomedicines. 2023; 11(9).
PMID: 37760897
PMC: 10525377.
DOI: 10.3390/biomedicines11092456.
Leone F, Evers-Casey S
Med Clin North Am. 2021; 106(1):99-112.
PMID: 34823737
PMC: 8630801.
DOI: 10.1016/j.mcna.2021.08.011.
Ionov I, Pushinskaya I, Gorev N, Frenkel D, Severtsev N
Psychopharmacology (Berl). 2021; 238(9):2471-2483.
PMID: 34002247
DOI: 10.1007/s00213-021-05870-3.
Shin M, Venton B
Anal Chem. 2018; 90(17):10318-10325.
PMID: 30073836
PMC: 6135655.
DOI: 10.1021/acs.analchem.8b02114.
Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
Mouhape C, Costa G, Ferreira M, Abin-Carriquiry J, Dajas F, Prunell G
Neurotox Res. 2018; 35(1):71-82.
PMID: 30006684
DOI: 10.1007/s12640-018-9931-1.
The neuroprotective effect of nicotine in Parkinson's disease models is associated with inhibiting PARP-1 and caspase-3 cleavage.
Lu J, Su P, Barber J, Nash J, Le A, Liu F
PeerJ. 2017; 5:e3933.
PMID: 29062606
PMC: 5651169.
DOI: 10.7717/peerj.3933.
Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.
Stetler R, Leak R, Gan Y, Li P, Zhang F, Hu X
Prog Neurobiol. 2014; 114:58-83.
PMID: 24389580
PMC: 3937258.
DOI: 10.1016/j.pneurobio.2013.11.005.
How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use?.
McKee S, Weinberger A
Annu Rev Clin Psychol. 2012; 9:649-74.
PMID: 23157448
PMC: 3651830.
DOI: 10.1146/annurev-clinpsy-050212-185549.
DARPP-32, Jack of All Trades… Master of Which?.
Yger M, Girault J
Front Behav Neurosci. 2011; 5:56.
PMID: 21927600
PMC: 3168893.
DOI: 10.3389/fnbeh.2011.00056.
Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats.
Gregorio M, Wietzikoski E, Ferro M, Silveira J, Vital M, Da Cunha C
Neurotox Res. 2009; 15(4):359-66.
PMID: 19384569
DOI: 10.1007/s12640-009-9041-1.
The road to discovery of neuronal nicotinic cholinergic receptor subtypes.
Collins A, Salminen O, Marks M, Whiteaker P, Grady S
Handb Exp Pharmacol. 2009; (192):85-112.
PMID: 19184647
PMC: 8759235.
DOI: 10.1007/978-3-540-69248-5_4.
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.
Grady S, Salminen O, Laverty D, Whiteaker P, McIntosh J, Collins A
Biochem Pharmacol. 2007; 74(8):1235-46.
PMID: 17825262
PMC: 2735219.
DOI: 10.1016/j.bcp.2007.07.032.
The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats.
Janhunen S, Mielikainen P, Paldanius P, Tuominen R, Ahtee L, Kaakkola S
Naunyn Schmiedebergs Arch Pharmacol. 2005; 371(6):480-91.
PMID: 16012872
DOI: 10.1007/s00210-005-1066-2.
Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.
Salin-Pascual R, De la Fuente J, Drucker-Colin R
Psychopharmacology (Berl). 1995; 121(4):476-9.
PMID: 8619011
DOI: 10.1007/BF02246496.
A role for the basal ganglia in nicotinic modulation of the blink reflex.
Evinger C, Basso M, Manning K, Sibony P, Pellegrini J, Horn A
Exp Brain Res. 1993; 92(3):507-15.
PMID: 8454014
DOI: 10.1007/BF00229040.
Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo.
CLARKE P
Br J Pharmacol. 1994; 111(2):414-8.
PMID: 8004385
PMC: 1909959.
DOI: 10.1111/j.1476-5381.1994.tb14750.x.
Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro.
CLARKE P
Br J Pharmacol. 1994; 111(2):406-13.
PMID: 8004384
PMC: 1909987.
DOI: 10.1111/j.1476-5381.1994.tb14749.x.
Effects of subacute administration of methamphetamine and nicotine on locomotor activity in transgenic mice expressing the human tyrosine hydroxylase gene.
Nabeshima T, Itoh A, Kobayashi K, Morita S, Mizuguchi T, Sawada H
J Neural Transm Gen Sect. 1994; 97(1):41-9.
PMID: 7888148
DOI: 10.1007/BF01277961.
Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.
Benwell M, Balfour D, Lucchi H
Psychopharmacology (Berl). 1993; 112(4):467-74.
PMID: 7871059
DOI: 10.1007/BF02244896.
